"Insulin, Short-Acting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Insulin derivatives and preparations that are designed to induce a rapid HYPOGLYCEMIC EFFECT.
Descriptor ID |
D061266
|
MeSH Number(s) |
D06.472.699.587.200.400 D12.644.548.586.200.400
|
Concept/Terms |
Insulin, Short-Acting- Insulin, Short-Acting
- Insulin, Short Acting
- Short-Acting Insulin
- Insulin, Rapid-Acting
- Insulin, Rapid Acting
- Rapid-Acting Insulin
|
Below are MeSH descriptors whose meaning is more general than "Insulin, Short-Acting".
Below are MeSH descriptors whose meaning is more specific than "Insulin, Short-Acting".
This graph shows the total number of publications written about "Insulin, Short-Acting" by people in this website by year, and whether "Insulin, Short-Acting" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Insulin, Short-Acting" by people in Profiles.
-
ISPAD Clinical Practice Consensus Guideline: Diabetic ketoacidosis in the time of COVID-19 and resource-limited settings-role of subcutaneous insulin. Pediatr Diabetes. 2020 12; 21(8):1394-1402.
-
The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring. Diabetes Res Clin Pract. 2020 Sep; 167:108354.
-
Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial. Diabetes Obes Metab. 2019 04; 21(4):837-843.
-
Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies. J Diabetes. 2018 Feb; 10(2):94-111.